Investors Overview Overview Investor Relations Investor Relations News Releases Presentations & Events Common Stock Information Stock Quote & Chart Analyst Coverage SEC Filings Corporate Governance Overview Board of Directors Committee Composition Management Team Corporate Factsheet Annual Reports Overview FRONT >> Quick Links Stock Info News Releases SEC Filings Analyst Coverage Presentations & Events Corporate Factsheet News Releases Nov 10 2021 Cyclacel Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update Nov 05 2021 Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Fadraciclib in Patients With Leukemias or Myelodysplastic Syndromes Oct 29 2021 Cyclacel Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Business Update FRONT >> News > View All View All News Events Nov 10 2021 at 4:30 PM EST Third Quarter 2021 Financial Results Sep 30 2021 at 2:00 PM EDT Cantor Fitzgerald Global Healthcare Conference Sep 21 2021 at 10:45 AM EDT Oppenheimer Fall Healthcare Life Sciences and MedTech Summit FRONT > Events - View All View All Events Featured Videos CEO Spiro Rombotis addressing Cancer Resistance Toolkit Email AlertsRSS FeedsPrint Page
Overview FRONT >> Quick Links Stock Info News Releases SEC Filings Analyst Coverage Presentations & Events Corporate Factsheet News Releases Nov 10 2021 Cyclacel Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update Nov 05 2021 Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Fadraciclib in Patients With Leukemias or Myelodysplastic Syndromes Oct 29 2021 Cyclacel Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Business Update FRONT >> News > View All View All News Events Nov 10 2021 at 4:30 PM EST Third Quarter 2021 Financial Results Sep 30 2021 at 2:00 PM EDT Cantor Fitzgerald Global Healthcare Conference Sep 21 2021 at 10:45 AM EDT Oppenheimer Fall Healthcare Life Sciences and MedTech Summit FRONT > Events - View All View All Events Featured Videos CEO Spiro Rombotis addressing Cancer Resistance
Nov 10 2021 Cyclacel Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
Nov 05 2021 Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Fadraciclib in Patients With Leukemias or Myelodysplastic Syndromes
Oct 29 2021 Cyclacel Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Business Update
